Intravenous artesunate recommended for patients with severe malaria: position statement from TropNetEurop.
Jelinek
Tomas
T
TropNetEurop coordinator, Berlin Institute of Tropical Medicine, Berlin, Germany. tomas.jelinek@charite.de
D000962:Antimalarials / Q000008:administration & dosage; D037621:Artemisinins / Q000008:administration & dosage*; D000077332:Artesunate; D021821:Communicable Diseases, Emerging / Q000276:immunology* / Q000517:prevention & control*; D005060:Europe / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D007275:Injections, Intravenous; D008288:Malaria / Q000188:drug therapy* / Q000453:epidemiology*; D011159:Population Surveillance; D017410:Practice Guidelines as Topic; D012717:Sesquiterpenes / Q000008:administration & dosage*; D012720:Severity of Illness Index; D016896:Treatment Outcome
D000962:Antimalarials; D037621:Artemisinins; D012717:Sesquiterpenes; D000077332:Artesunate